Anti-Inflammation effects of Radix Astragali Plays an Important Role in Ameliorating Type 2 Diabetes Mellitus

Radix Astragali (RA), known as Huangqi in traditional Chinese Medicine, is one of the most popular herbal medicines learnt to treat diabetes. However, its scientific effect and mechanism needs to be established. It has been reported that RA displayed various effects such as oxidative stress, scavenging free radicals, and ameliorating inflammation function etc. Type 2 diabetes (T2DM) has been recognized as a low-level inflammatory disease. Abundant studies have indicated RA could significantly reduce the diabetic inflammation. The aim of this review is to highlight advances of RA on T2DM from the perspective of inflammation.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-11-24

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.17352/2455-8583.000005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• An Aqueous Extract of Radix Astragali, Angelica sinensis, and Panax notoginseng Is Effective in Preventing Diabetic Retinopathy

  2013cited by this paper
• Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance

  2012cited by this paper
• Astragaloside IV attenuates Toll-like receptor 4 expression via NF-κB pathway under high glucose condition in mesenchymal stem cells.

  2012cited by this paper
• Loss of Pulsatile Insulin Secretion: A Factor in the Pathogenesis of Type 2 Diabetes?

  2012cited by this paper
• Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats

  2012cited by this paper
• Astragalus Root and Elderberry Fruit Extracts Enhance the IFN-β Stimulatory Effects of Lactobacillus acidophilus in Murine-Derived Dendritic Cells

  2012cited by this paper
• Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing.

  2012cited by this paper
• Phytoestrogen calycosin‐7‐O‐β‐D‐glucopyranoside ameliorates advanced glycation end products‐induced HUVEC damage

  2011cited by this paper
• Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?

  2011cited by this paper
• Diabetes is an inflammatory disease: evidence from traditional Chinese medicines

  2011cited by this paper
• Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration.

  2011cited by this paper
• Genistein attenuates D-galactose-induced oxidative damage through decreased reactive oxygen species and NF-κB binding activity in neuronal PC12 cells.

  2011cited by this paper
• The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products.

  2009cited by this paper
• Insulin Resistance and Glucose Homeostasis in Peritoneal Dialysis

  2009cited by this paper
• The role of inflammatory cytokines in diabetes and its complications.

  2008cited by this paper
• Thiazolidinediones and bone.

  2007cited by this paper
• Buyang Huanwu Decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains.

  2007cited by this paper
• Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis.

  2007cited by this paper
• Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro.

  2006cited by this paper
• Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia

  2006cited by this paper
• Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro

  2006cited by this paper
• Inflammation and insulin resistance.

  2006cited by this paper
• [The protective effects of Radix Astragali and Rhizoma Ligustici chuanxiong on endothelial dysfunction in type 2 diabetic patients with microalbuminuria].

  2005cited by this paper
• Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by L-glutamate.

  2005cited by this paper
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

  2005cited by this paper
• Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase

  2004cited by this paper
• Thiazolidinediones and Blood Lipids in Type 2 Diabetes

  2003cited by this paper
• Effects of calycosin on the impairment of barrier function induced by hypoxia in human umbilical vein endothelial cells.

  2003cited by this paper
• Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.

  2002cited by this paper
• PPARγ and the thiazolidinediones: molecular basis for a treatment of ‘Syndrome X’?

  2002cited by this paper
• Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

  2002cited by this paper
• High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.

  2002cited by this paper
• Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

  2002cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 *

  2000cited by this paper
• Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats.

  2000cited by this paper
• Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

  2000cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

  1998cited by this paper
• Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells.

  1997cited by this paper
• IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

  1996cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Role of Oxidative Stress in Development of Complications in Diabetes

  1991cited by this paper

• Benefits of Huangqi Herbal Treatment for Patients with Diabetes Mellitus

  2023cites this paper